Not Ranked
This scheme is not ranked by CRISIL.
View Top ranked funds in other categories
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | - | - |
| 3 mth | - | - |
| 6 mth | - | - |
| 1 year | - | - |
| 2 year | - | - |
| 3 year | - | - |
| 5 year | - | - |
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2011 | -14.6 | 1.9 | -10.5 | - | -21.3 |
| 2010 | -0.9 | -0.9 | 11.8 | 0.4 | 13.0 |
| 2009 | -12.2 | 44.1 | 15.0 | -4.5 | 41.5 |
| 2008 | -29.1 | -12.5 | -7.4 | -29.0 | -60.1 |
| 2007 | -12.7 | 10.5 | 4.7 | 17.0 | 17.4 |
* Returns over 1 year are Annualised
Fund returns v/s Category average ()
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -- | -- | -- | -- | -- | -- | -- |
| Category avg | 0.6 | -7.3 | 8.2 | -27.1 | -- | -6.1 | -- |
| Difference of Fund returns and Category returns | -- | -- | -- | -- | -- | -- | -- |
| Best of category | -6.9 | -7.3 | -7.8 | -27.1 | -- | -6.1 | -- |
| Worst of category | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Benchmark returns # | -5.7 | -6.1 | 4.5 | -9.4 | -1.1 | 4.8 | 2.1 |
| Difference of Fund returns and Benchmark returns | -- | -- | -- | -- | -- | -- | -- |
Investment Objective
Chola Global Advantage is an open-ended equity fund. The objective of the scheme seeking to provide long term capital appreciation and/or income distribution by investing predominantly in equity/equity related instruments of Indian companies with export competitiveness and Indian companies which have or which are expanding their business in global markets.
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Growth |
| Launch date | May 16, 2005 |
| Benchmark | S&P CNX 500 |
| Asset Size (Rs cr) | 1.12 (Sep-30-2011) |
| Minimum Investment | Rs.5000 |
| Last Dividend | N.A. |
| Bonus | N.A. |
| Fund Manager | Bajrang Kumar Bafna View performance of schemes managed by the Fund Manager |
| Notes | L&T Global Advantage Fund has been merged with L&T Growth Fund w.e.f. September 10, 2011. |
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit load of 1% if redeemed within 1 year from the date of allotment. |
| Regd. Office | World Trade Centre, Centre 1, 27th Floor, Unit 1, Cuffe Parede, Mumbai , 400 005 |
|---|---|
| Tel. No. | 022 - 61366600 |
| Fax No. | 022-61366603/ 04 |
| ltmf@lntmf.com | |
| Website | www.lntmf.com |
| Crisil Rank | Assets (Rs.cr) |
||||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Sundaram Capex Oppor.- IP (G) | Not Ranked |
0.32 | 0.0 | 0.0 | -- | -- | -- |
| ICICI Pru Real Est-Sec -RP (G) | Not Ranked |
303.28 | 0.0 | 0.0 | -- | -- | -- |
| Mirae Ultra STBF - SIP (G) | Not Ranked |
257.04 | 0.0 | 0.0 | -- | -- | -- |
| Mirae Liquid Fund - SIP (G) | Not Ranked |
231.07 | 0.0 | 0.0 | -- | -- | -- |
| Templeton (I) TMA- Liquid (G) | Not Ranked |
41.93 | 0.0 | 0.0 | -- | -- | -- |
| * Returns over 1 year are Annualised | More » | ||||||
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| Dr Reddys Labs | Pharmaceuticals | 0.37 | 8.85 |
| Biocon | Pharmaceuticals | 0.33 | 7.84 |
| Reliance | Oil & Gas | 0.31 | 7.41 |
| Infosys | Technology | 0.29 | 6.93 |
| Clariant | Chemicals | 0.28 | 6.65 |
| Cipla | Pharmaceuticals | 0.27 | 6.44 |
| Persistent | Technology | 0.24 | 5.74 |
| Wipro | Technology | 0.22 | 5.24 |
| Ipca Labs | Pharmaceuticals | 0.18 | 4.36 |
| Voltas | Conglomerates | 0.14 | 3.38 |
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Pharmaceuticals | 27.49 | 27.49 | 17.55 |
| Technology | 25.35 | 25.35 | 21.53 |
| Chemicals | 8.87 | 9.05 | 2.21 |
| Oil & Gas | 7.41 | 9.68 | 6.80 |
| Automotive | 4.55 | 17.60 | 3.70 |
| Conglomerates | 3.38 | 4.04 | 3.38 |
| Equity | 82.63 |
| Others | 2.04 |
| Debt | 0.00 |
| Mutual Funds | N.A |
| Money Market | 19.28 |
| Cash / Call | -3.95 |
| Holdings | (%) |
|---|---|
| Top 5 | 37.68 |
| Top 10 | 62.84 |
| Sector | (%) |
|---|---|
| Top 3 | 61.71 |
CEO exodus leaves MF sector in quandry
Apr 16, 2012 at 21:49 | Source:
Oct 25, 2011
Oct 25, 2011
Oct 25, 2011
Quick Links